FUL logo

FUL

H. B. Fuller Company

$60.39
-$0.56(-0.92%)
76
Overall
85
Value
91
Tech
52
Quality
Market Cap
$3.14B
Volume
403.91K
52W Range
$47.56 - $77.77
Target Price
$68.57

Company Overview

Mkt Cap$3.14BPrice$60.39
Volume403.91KChange-0.92%
P/E Ratio24.1Open$61.47
Revenue$3.6BPrev Close$60.95
Net Income$130.3M52W Range$47.56 - $77.77
Div Yield0.94%Target$68.57
Overall76Value85
Quality52Technical91

No chart data available

About H. B. Fuller Company

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives, such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven and hygiene, and health and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives comprising reactive, light cure, two-part liquids, polyurethane, silicone, film, and fast cure products to the durable assembly, performance wood and textile, transportation, electronics, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for tile setting, commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly to customers, as well as through distributors and retailers in North America, Latin America, Europe, India, the Middle East, Africa, and the Asia Pacific. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.

Sector: Basic Materials
Industry: Specialty Chemicals

Latest News

Fulcrum Therapeutics (FULC) Receives a Buy from Roth MKM

In a report released today, from Roth MKM reiterated a Buy rating on Fulcrum Therapeutics, with a price target of $15.00. In addition to Roth MKM, ...

TipRanks Auto-Generated Intelligence Newsdesk5 days ago

Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY), Fulcrum Therapeutics (FULC) and Arcellx Inc (ACLX)

Brian Anderson5 days ago

Cantor Fitzgerald Remains a Buy on Fulcrum Therapeutics (FULC)

TipRanks Auto-Generated Intelligence Newsdesk5 days ago

Stifel Nicolaus Remains a Buy on Fulcrum Therapeutics (FULC)

TipRanks Auto-Generated Intelligence Newsdesk5 days ago

Fulcrum Therapeutics (FULC) Receives a Buy from Oppenheimer

TipRanks Auto-Generated Intelligence Newsdesk5 days ago
ABCD
1SymbolPriceChangeVol
2FUL$60.39-0.9%403.91K
3
4
5
6

Get H. B. Fuller Company Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.